Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry

Journal of Nuclear Medicine

Volumn 48, Issue 5, 2007, Pages 685-692

  Dinant, Sander ^a   De Graaf, Wilmar ^a   Verwer, Bart J ^a   Bennink, Roelof J ^a   Van Lienden, Krijn P ^a   Gouma, Dirk J ^a   Van Vliet, Arlène K ^a   Van Gulik, Thomas M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CT volumetry; Hepatectomy; Hepatobiliary scintigraphy; Iminodiacetic acid; Liver failure

Indexed keywords

MEBROFENIN TC 99M; DIAGNOSTIC AGENT; IMINO ACID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M MEBROFENIN; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ADULT; AGED; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BILE LEAKAGE; CHOLANGITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DELIRIUM; FEMALE; HEART FAILURE; HEPATOBILIARY SCINTISCANNING; HEPATOBILIARY SYSTEM TUMOR; HUMAN; LIVER ABSCESS; LIVER FAILURE; LIVER NECROSIS; LIVER RESECTION; LUNG INSUFFICIENCY; MALE; PERITONITIS; PLEURA FLUID; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; URINARY TRACT INFECTION; VOLUMETRY; WOUND DEHISCENCE; WOUND INFECTION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; HEPATOBILIARY SYSTEM; LIVER; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; NETHERLANDS; PROGNOSIS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL; SURVIVAL RATE; THREE DIMENSIONAL IMAGING;

ADULT; AGED; BILIARY TRACT; COMORBIDITY; FEMALE; HEPATECTOMY; HUMANS; IMAGING, THREE-DIMENSIONAL; IMINO ACIDS; LIVER; LIVER FAILURE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250658132     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.038430     Document Type: Article

References (36)

1. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406.
2. Poon RT, Fan ST, Lo CM, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg. 2002;236:602-611.
3. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
4. Nagino M, Kamiya J, Uesaka K, et al. Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg. 2001;25:1277-1283.
5. Das BC, Isaji S, Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg. 2001;25:266-272.
6. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229:210-215.
7. Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK, Belghiti J. The small remnant liver after major liver resection: how common and how relevant? Liver Transpl. 2003;9(suppl):S18-S25.
8. Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512-519.
9. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521-527.
10. Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208-217.
11. Wakabayashi H, Ishimura K, Okano K, et al. Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery. 2002;131:26-33.
12. Heyman S. Hepatobiliary scintigraphy as a liver function test. J Nucl Med. 1994;35:436-437.
13. Ekman M, Fjalling M, Friman S, Carlson S, Volkmann R. Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nucl Med Commun. 1996;17:235-242.
14. Hendrikse NH, Kuipers F, Meijer C, et al. In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein. Cancer Chemother Pharmacol. 2004;54:131-138.
15. 99mTc-mebrofenin scintigraphy with indocyanine green clearance test. Liver Int. 2004;24:117-123.
16. Bennink RJ, Dinant S, Erdogan D, et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med. 2004;45:965-971.
17. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;1:863-871.
18. Shoup M, Gonen M, D'Angelica M, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325-330.
19. Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumour). Ann Surg Oncol. 2006;13:872-880.
20. Dinant S, Gerhards MF, Busch ORC, Obertop H, Gouma DJ, van Gulik TM. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB. 2005;7:263-267.
21. Lee WM. Acute liver failure. Am J Med. 1994;96(suppl):2S-9S.
22. Fingerote RJ, Bain VG. Fulminant hepatic failure. Am J Gastroenterol. 1993;88:1000-1010.
23. Archibald S, Bhandari M, Thoma A. Users' guides to the surgical literature: how to use an article about a diagnostic test. Can J Surg. 2001;44:17-23.
24. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355-373.
25. Reisman Y, van Dam GM, Gips CH, Lavelle SM, Euricterus PM. Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group. Hepatogastroenterology. 1997;44:982-989.
26. Redaelli CA, Dufour JF, Wagner M, et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg. 2002;235:77-85.
27. Nonami T, Nakao A, Kurokawa T, et al. Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology. 1999;46:1669-1672.
28. 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases: validation of the use of SPECT and a new indicator. Ann Nucl Med. 2003;17:181-188.
29. Kokudo N, Vera DR, Tada K, et al. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg. 2002;26:1342-1347.
30. Mitsumori A, Nagaya I, Kimoto S, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med. 1998;25:1377-1382.
31. 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med. 1999;40:1644-1651.
32. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304-309.
33. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165-175.
34. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507-517.
35. Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery. 2005;137:148-155.
36. Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95-101.